My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 596

    1.

    Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.

    Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S, Garvey WT, Schmaier AH; DCCT/EDIC Study Group.

    Diabetes. 2003 May;52(5):1215-21.PMID: 12716755 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.

    Nannipieri M, Penno G, Rizzo L, Pucci L, Bandinelli S, Mattei P, Taddei S, Salvetti A, Navalesi R.

    Diabetes Care. 1997 Jun;20(6):1019-26.PMID: 9167118 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.

    Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey WT; DCCT/ECIC STUDY GROUP.

    Diabetes Care. 2003 May;26(5):1439-48.PMID: 12716802 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

    Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

    Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

    Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.

    Diabetologia. 1998 Jun;41(6):684-93.PMID: 9662051 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration.

    Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A.

    Diabetes. 2000 Jul;49(7):1258-63.PMID: 10909986 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Increased secretion of TGF-beta1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy.

    Korpinen E, Groop PH, Fagerudd JA, Teppo AM, Akerblom HK, Vaarala O.

    Diabet Med. 2001 Feb;18(2):121-5.PMID: 11251675 [PubMed - indexed for MEDLINE]Related articles

    8.

    Incipient and overt diabetic nephropathy in African Americans with NIDDM.

    Dasmahapatra A, Bale A, Raghuwanshi MP, Reddi A, Byrne W, Suarez S, Nash F, Varagiannis E, Skurnick JH.

    Diabetes Care. 1994 Apr;17(4):297-304.PMID: 8026285 [PubMed - indexed for MEDLINE]Related articles

    9.

    YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.

    Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H.

    Diabetes Care. 2009 Feb;32(2):323-8. Epub 2008 Oct 28.PMID: 18957531 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.

    Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N.

    Diabetologia. 2004 Jun;47(6):1020-8. Epub 2004 May 29.PMID: 15170497 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.

    Diabetes Care. 1996 Dec;19(12):1382-7.PMID: 8941468 [PubMed - indexed for MEDLINE]Related articles

    12.

    Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.

    Jaffa AA, Usinger WR, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, Lopes-Virella M, Luttrell LM, Wilson PW; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Group.

    J Clin Endocrinol Metab. 2008 May;93(5):1893-900. Epub 2008 Mar 4.PMID: 18319310 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Diurnal blood pressure pattern may predict the increase of urinary albumin excretion in normotensive normoalbuminuric type 1 diabetes mellitus patients.

    Lengyel Z, Rosivall L, Németh C, Tóth LK, Nagy V, Mihály M, Kammerer L, Vörös P.

    Diabetes Res Clin Pract. 2003 Dec;62(3):159-67.PMID: 14625130 [PubMed - indexed for MEDLINE]Related articles

    14.

    Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

    Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

    Arch Intern Med. 1998 May 11;158(9):998-1004.PMID: 9588433 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.

    Diabetes Care. 2003 Sep;26(9):2632-6.PMID: 12941731 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Significance of arterial blood pressure for the development of microalbuminuria and retinopathy in type I diabetes mellitus]

    Watschinger B, Schnack C, Bruck S, Stelzer N, Gisinger C, Schernthaner G.

    Klin Wochenschr. 1988 Nov 1;66(21):1074-8. German. PMID: 3236757 [PubMed - indexed for MEDLINE]Related articles

    17.

    Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.

    Lutale JJ, Thordarson H, Abbas ZG, Vetvik K.

    BMC Nephrol. 2007 Jan 15;8:2.PMID: 17224056 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Plasma N-terminal pro-brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy.

    Siebenhofer A, Ng LL, Plank J, Berghold A, Hödl R, Pieber TR.

    Diabet Med. 2003 Jul;20(7):535-9.PMID: 12823233 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

    Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Dräger AM, Doni A, van Hinsbergh VW, Stehouwer CD.

    Diabetologia. 1999 Mar;42(3):351-7.PMID: 10096789 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

    Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity